See Insiders' Hot Stocks on TipRanks >> Based on Arbutus Biopharma's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $3.89 million and a GAAP net loss of $17.09 million. In comparison, last year the company earned a revenue of $12.56 million and had a GAAP net loss of $14.19 million TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada. Read More on ABUS: